- Home
- CRDL vs TSQ Comparison
CRDL vs TSQ Comparison
Compare CRDL & TSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- TSQ
- Stock Information
- Founded
- CRDL 2017
- TSQ 1996
- Country
- CRDL Canada
- TSQ United States
- Employees
- CRDL N/A
- TSQ N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- TSQ Broadcasting
- Sector
- CRDL Health Care
- TSQ Consumer Discretionary
- Exchange
- CRDL Nasdaq
- TSQ Nasdaq
- Market Cap
- CRDL 126.5M
- TSQ 115.3M
- IPO Year
- CRDL N/A
- TSQ 2000
- Fundamental
- Price
- CRDL $1.09
- TSQ $7.06
- Analyst Decision
- CRDL Strong Buy
- TSQ Buy
- Analyst Count
- CRDL 2
- TSQ 1
- Target Price
- CRDL $9.00
- TSQ $13.00
- AVG Volume (30 Days)
- CRDL 749.6K
- TSQ 42.7K
- Earning Date
- CRDL 11-13-2025
- TSQ 11-06-2025
- Dividend Yield
- CRDL N/A
- TSQ 11.45%
- EPS Growth
- CRDL N/A
- TSQ N/A
- EPS
- CRDL N/A
- TSQ 2.23
- Revenue
- CRDL N/A
- TSQ $447,247,000.00
- Revenue This Year
- CRDL N/A
- TSQ N/A
- Revenue Next Year
- CRDL N/A
- TSQ $4.47
- P/E Ratio
- CRDL N/A
- TSQ $3.14
- Revenue Growth
- CRDL N/A
- TSQ N/A
- 52 Week Low
- CRDL $0.77
- TSQ $6.47
- 52 Week High
- CRDL $2.54
- TSQ $10.79
- Technical
- Relative Strength Index (RSI)
- CRDL 44.63
- TSQ 50.11
- Support Level
- CRDL $1.04
- TSQ $7.14
- Resistance Level
- CRDL $1.10
- TSQ $7.10
- Average True Range (ATR)
- CRDL 0.06
- TSQ 0.16
- MACD
- CRDL 0.01
- TSQ 0.00
- Stochastic Oscillator
- CRDL 38.24
- TSQ 30.00
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About TSQ Townsquare Media Inc.
Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the premier local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.